Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
67 hedge funds and large institutions have $33.6M invested in Applied Genetic Technologies Corporation in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 17 closing their positions.
76% more call options, than puts
Call options by funds: $188K | Put options by funds: $107K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
13% less funds holding
Funds holding: 77 → 67 (-10)
29% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 24
33% less capital invested
Capital invested by funds: $50.3M → $33.6M (-$16.7M)
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$588K |
| 2 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$413K |
| 3 |
BlackRock
New York
|
+$255K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$227K |
| 5 |
SIM
Spark Investment Management
New York
|
+$223K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.42M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$856K |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$852K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$795K |
| 5 |
Goldman Sachs
New York
|
-$732K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
76
Credit Suisse
Zurich,
Switzerland
| – | -$186K | -36,554 | Closed |
|
77
UBS Group
Zurich,
Switzerland
| – | -$161K | -31,703 | Closed |
|
78
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$107K | -20,900 | Closed |
|
|
TI
79
Trexquant Investment
Stamford,
Connecticut
| – | -$102K | -20,000 | Closed |
|
|
DTL
80
Dynamic Technology Lab
Singapore
| – | -$74K | -14,667 | Closed |
|
81
Jane Street
New York
| – | -$62K | -12,064 | Closed |
|
82
JP Morgan Chase
New York
| – | -$41K | -8,012 | Closed |
|
83
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$7K | -1,369 | Closed |
|
|
AG
84
Advisor Group
Phoenix,
Arizona
| – | -$3K | -600 | Closed |
|
AGTC Hedge Fund Activity: Q3 2017 in Review
67 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q3 2017, worth a combined $33.6M — down 33% from $50.3M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of AGTC and 8 opened new positions — a net loss of 9 holders — while 24 trimmed existing stakes and 17 added.
The largest buyer was Dimensional Fund Advisors, adding an estimated $588K. The largest seller was Millennium Management, cutting an estimated $1.42M.
- 67 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q3 2017, down from 77 in Q2 2017.
- Funds reported $33.6M of Applied Genetic Technologies Corporation stock for Q3 2017, down 33% quarter-over-quarter.
- 8 funds opened new Applied Genetic Technologies Corporation positions in Q3 2017 and 17 closed out, a net change of -9 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q3 2017 was Dimensional Fund Advisors, an estimated $588K added.
- The largest Applied Genetic Technologies Corporation seller in Q3 2017 was Millennium Management, an estimated $1.42M sold.
Based on aggregated 13F filings for Q3 2017.